PubMed · 9340329
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
N Marangos. 1997. [Cochlear implants].. https://pubmed.ncbi.nlm.nih.gov/9340329/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
We describe a novel signal processing strategy for cochlear implants designed to emphasize stochastic independence across the excited neural population. The strategy is based on the observation that high rate pulse trains may produce random spike patterns in auditory nerve fibers that are statistically similar to those produced by spontaneous activity in the normal cochlea. We call this activity 'pseudospontaneous'. A supercomputer-based computational model of a population of auditory nerve fibers suggests that different average rates of pseudospontaneous activity can be created by varying the stimulus current of a fixed-amplitude, high-rate pulse train, e.g. 5000 pps. Electrically-evoked compound action potentials recorded in a human cochlear implant subject are consistent with the hypothesis that such a stimulus can desynchronize the fiber population. This desynchronization may enhance neural representation of temporal detail and dynamic range with a cochlear implant and eliminate a major difference between acoustic and electric hearing.
Explore the source record for details and available documents.
The Clarion cochlear implant is the result of many years of research and development, first at the University of California, San Francisco and the Research Triangle Institute of North Carolina, and then at Advanced Bionics Corporation in Sylmar, California. Approved by the US Food and Drug Administration after carefully monitored investigational clinical trials in both the adult and pediatric populations, it has now been implanted in approximately 3,000 patients worldwide. A fully flexible, programmable system, the Clarion offers multiple strategies and options in speech processing. The coupling mode, the stimulating waveform, and the temporal pattern of stimulation can be selected to allow each patient an opportunity to be fitted with the strategy that offers the highest level of performance. This paper describes the current status of the Clarion system. However, Clarion development has been a dynamic process, and from its initial introduction in 1991, the system has been modified and continually improved. The process of improvement and advancement is ongoing. New speech processing strategies and hardware developments are briefly summarized at the conclusion of this paper.